The PE Ratio as of September 2024 (TTM) for Mydecine Innovations Group Inc. (MYCOF) is -0.04

According to Mydecine Innovations Group Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.04. This represents a change of -64.50% compared to the average of -0.11 of the last 4 quarters.

Mydecine Innovations Group Inc. (MYCOF) Historical PE Ratio (quarterly & annually)

How has MYCOF PE Ratio performed in the past?

The mean historical PE Ratio of Mydecine Innovations Group Inc. over the last ten years is -1.57. The current -0.04 PE Ratio has changed 155.52% with respect to the historical average. Over the past ten years (40 quarters), MYCOF's PE Ratio was at its highest in in the December 2022 quarter at 5.78. The PE Ratio was at its lowest in in the December 2014 quarter at -7.83.

Mydecine Innovations Group Inc. (MYCOF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Mydecine Innovations Group Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Mydecine Innovations Group Inc. (MYCOF) Average PE Ratio

How has MYCOF PE Ratio performed in the past?

The current PE Ratio of Mydecine Innovations Group Inc. (MYCOF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Mydecine Innovations Group Inc. (MYCOF) PE Ratio vs. Peers

How is MYCOF’s PE Ratio compared to its peers?

Mydecine Innovations Group Inc.’s PE Ratio is less than Green Cures & Botanical Distribution Inc. (1.81), less than Cann American Corp. (0.41), greater than Rimrock Gold Corp. (-26.63), greater than Galexxy Holdings, Inc. (-6.04), greater than Indoor Harvest Corp (-0.11), greater than CBD Global Sciences Inc. (-0.28), greater than MGC Pharmaceuticals Limited (-0.53), greater than Target Group Inc. (-18.07), greater than Aequus Pharmaceuticals Inc. (-0.94), greater than Filament Health Corp. (-2.42), greater than Aleafia Health Inc. (-0.31), greater than Pharmagreen Biotech Inc. (-4.44), greater than Endexx Corporation (-1.43), less than Green Growth Brands Inc. (-0.00), less than HempAmericana, Inc (0), less than Radient Technologies Inc. (0), less than Nextleaf Solutions Ltd. (0), greater than Abattis Bioceuticals Corp. (-16.34), less than null (-0.02),

Build a custom stock screener for Mydecine Innovations Group Inc. (MYCOF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mydecine Innovations Group Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mydecine Innovations Group Inc. (MYCOF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mydecine Innovations Group Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.